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Abstract
Background: Influenza causes substantial morbidity and mortality worldwide, yet few data exist on influenza
infection rates in tropical, developing countries. In 2011, we established the Nicaraguan Pediatric Influenza Cohort
Study (NPICS) to study the burden and seasonality of influenza in Nicaraguan children. Here we describe the study
design, methods, and participation data of the NPICS for 2011–2013.
Methods/Design: A total of 1532 children aged 0 to 12 years were enrolled into the study in 2011, and an
additional 401 children were enrolled between 2012 and 2013. Children were provided with all of their medical
care through the study, and data on medical visits were recorded systematically. A number of surveys were
conducted together with a blood sample annually, including a height and weight measurement, a socio-economic
status and risk factor survey, and a breastfeeding survey.
Discussion: Unique features of our study include the customized low-cost, open-source informatics system as well
as the development of methods to leverage infrastructure and resources by conducting multiple studies in the
same setting while maximizing protocol adherence and quality control. These methods should be useful to others
conducting large cohort studies, particularly in low-resource settings.
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Background
Influenza causes substantial morbidity and mortality
worldwide, with an estimated 1 billion cases and 3–5
million cases of severe disease annually [1]. In tropical
developing countries, much remains to be elucidated
about the burden and epidemiology of seasonal influ-
enza. The paucity of data is due to both the lack of re-
sources as well as the relative importance of other
diseases in these regions. In addition, influenza wasn’t
thought to constitute a major disease burden in the tro-
pics [2]. However, recent studies have found that devel-
oping countries have a substantial burden of influenza,
particularly in young children [3–8]. To study the sea-
sonality and burden of influenza in Nicaraguan children,
we established the Nicaraguan Pediatric Influenza Co-
hort Study (NPICS).
Large-scale prospective cohort studies are notoriously
resource-intensive to conduct. As a result, there are rela-
tively few opportunities to perform cohort studies, and
they are often not conducted despite established scien-
tific interest and public health need. In infectious disease
research, studies usually focus on a single pathogen or
syndrome with occasional subsequent use of samples to
investigate other pathogens. Here, we have developed a
dual cohort for dengue and influenza. Overall, our study
sites in Nicaragua were developed over 27 years of close
collaboration with the Ministry of Health, including nu-
merous capacity building activities. The cohort site was
first established for dengue research studies in 2004 and
later expanded to include influenza and other respiratory
viruses [9, 10]. Study researchers have spent 8 years build-
ing extensive community infrastructure and developing
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local skills for influenza research. This led to a first influ-
enza cohort study (2007-2010) and then to the NPICS
(2011-present).
The objectives of NPICS are: to estimate the incidence
of influenza in Nicaraguan children; to investigate the
seasonality of influenza in Nicaragua, a tropical country;
to evaluate risk factors for influenza virus infection; and
to analyze the genetic relation of viruses circulating in
Nicaragua to those circulating in the Northern and
Southern hemispheres. In addition, the study aims to
build capacity at the local site and disseminate scientific
knowledge.
Methods/Design
Study site, population and design
The NPICS is conducted in District II of Managua,
Nicaragua, at the Health Center Sócrates Flores Vivas
(HCSFV). The district is adjacent to Lake Managua and
includes neighborhoods ranging from low to middle
class, including several areas classified as urban slums.
The streets of District II are largely paved, all residents
have access to electricity, and city water service varies
(0–24 h/day), with most residents reporting ≤8 h of ser-
vice. Person-density in study neighborhoods included
ranges from ≥10,000 to ≤57,000 persons/km2, with a
majority of participants living in areas with 14,000–
20,000 persons/km2. The HCSFV includes a clinical la-
boratory and provides primary medical services to a
population of ~61,411. Molecular and serological test-
ing for influenza is performed at the National Virology
Laboratory (NVL) of the Centro Nacional de Diagnós-
tico y Referencia (CNDR), which is a WHO National
Influenza Center. Both the CNDR and the HCSFV are
part of the Nicaraguan Ministry of Health.
The study population consists of children aged 0-14
years who reside in District II of Managua. Initially the
study consisted of children aged 0-12 years, however in
2013 the study was expanded to allow children to con-
tinue to participate until 14 years of age. At enrollment,
a clinical history, socio-demographic survey and house-
hold survey are collected. Each March/April, an annual
blood collection is performed on children >6 months of
age, a healthy height and weight is recorded, and breast-
feeding, socio-demographic, and household surveys are
administered.
Recruitment
To maximize follow-up time of participants and thus in-
formation on infection history, initial enrollment of three-
to eleven-year-old children was done through a random
selection of all participants from our previous influenza
cohort study [8]. That study was contiguous with the
NPICS and consisted of non-immunocompromised chil-
dren 2–13 years old within the HCSFV catchment area,
who were recruited through house-to-house visits. Add-
itional children ≤2 years were recruited for NPICS
through house-to-house visits. Each month, newborn in-
fants aged ≤4 weeks are enrolled into the NPICS. Parents
or guardians of participants were briefly informed about
the NPICS by study staff. If the parent or guardian indi-
cated interest, study staff read the informed consent form
aloud, which the parent or guardian then signed if they
elected to have their child participate. Verbal assent was
obtained from all children aged six and over. No monetary
incentives were offered for participation.
The study consent form consists of three parts: the
primary consent form (Part A), consent for future use
and storage (Part B), and consent for genetic studies
(Part C). To increase compliance with consent protocols,
the three consent forms are printed on differently col-
ored paper, enabling both field workers and supervisors
to easily identify missing components. To facilitate
tracking of consent forms and to minimize data entry er-
rors, all consent forms are barcoded. Consent forms are
stored in order of study code to facilitate rapid retrieval,
separately from other study documents in locked cabi-
nets, in accordance with good clinical practice (GCP).
Yearly survey and sample collection
Each March/April, annual surveys are conducted and a
blood sample is collected, before the influenza season
begins, typically in June. Annual surveys include a socio-
economic and household risk factor questionnaire, a
breastfeeding questionnaire, height and weight, and a
satisfaction questionnaire. Survey data are collected dir-
ectly into a tablet computer or smart phone, with home
factors (i.e., variables that are constant between house-
hold members) collected separately from participant-
specific factors. Blood samples of 7 ml are collected
from cohort participants aged ≥2 years and 3 ml from
children ≥6 months and <2 years.
The annual sampling and survey is divided into two
phases. In the first phase, all participants are encouraged
to come to the HCSFV and are contacted via posted no-
tices throughout the HCSFV, text messaging, and tele-
phone calls. The annual survey and sampling at the
HCSFV is divided into 7 stations; registration, identifica-
tion, informed consent, height-and-weight, surveys,
blood sampling, and study gift. To route participants
through the stations in an orderly fashion, laminated
numbered cards are used, with each station assigned a
unique color for their cards. When participants arrive at
the HCSFV, they are immediately routed to registration,
where they are identified by fingerprint or study ID card
and their contact information and basic demographic in-
formation is confirmed. Children then continue to the
height-and-weight station. Each child is measured with-
out shoes in light clothing on a digital scale for weight
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(Seca 874, Hamburg, Germany) and using a portable sta-
diometer for height (Seca 213). Children <2 are mea-
sured using a digital baby scale (Detecto 8440, Webb
City, MO) and an infantometer (Seca 416). Measure-
ments are taken twice and entered directly into a smart
phone or tablet using a custom app, which automatically
calculates the difference between the two measurements
and prompts the user to take a third measurement if the
difference is ≥5 %. Next, participants move to the survey
station, where staff administer the study factor surveys
(see Table 1). Finally, subjects move to the sampling sta-
tion for collection of a blood sample.
In the second phase, study teams are pre-assigned a
set of participants (who did not attend the HCSFV in
the first phase) to visit, maps of the location of each
team’s set are printed, and GPS points and participants’
information are downloaded into mobile devices.
Throughout the day, data are transferred from the field
staff ’s devices to a customized study database. This pro-
vides near real-time monitoring of field activities, enabling
rapid assessment of progress, efficient reassignment of
participant visits when necessary, and effective planning of
the next day’s visits [11]. Maps showing location and sta-
tus of the participants are generated in the team’s smart
phones and in a web page using the Google maps API.
Case surveillance and selection for respiratory virus
testing
The primary outcomes of this study are laboratory-
confirmed influenza and influenza-like illness. A case of
laboratory-confirmed influenza is defined as a positive
test for influenza A or B by RT-PCR. The definition of
influenza-like-illness used in this study is a fever of
37.8 °C with a cough and/or sore throat. Study partici-
pants are provided with all of their primary medical care
and laboratory testing free of charge. Study physicians
and nurses are available at the HCSFV 24 h/day,
365 days/year. Data on all medical and field visits are
collected systematically on standardized data collection
forms or directly into tablet computers or smart phones.
Parents of participants agreed to bring their child(ren)
in to the HCSFV at the first sign of fever. Upon presen-
tation at the HCSFV, participants identify themselves in
the reception area. All participants have a fingerprint
scan on file and are issued a barcoded ID card. Confirm-
ation of study participation is performed by scanning ei-
ther the participant’s study ID card or fingerprint. The
participant is then directed to the study area, where a
study nurse measures and records their height, weight,
and tympanic temperature. Next, the child is examined
by a study physician, who records information systemat-
ically on the history of illness and current symptoms.
Data on >80 variables are collected, including a sec-
ond tympanic temperature, blood pressure, respiratory
and heart rates, lower and upper respiratory symp-
toms, gastrointestinal symptoms, and nutritional sta-
tus. The criteria for influenza testing in this study is
illness onset within 4 days with a fever or history of
a fever, as reported by the parent, and cough and/or
onset for children ≥2 years, or fever or reported fever
for those <2 years. In addition, any child presenting with
clinical pneumonia or severe respiratory illness who is
referred to tertiary care is tested for influenza. All
children who fulfill the influenza testing criteria are
scheduled for follow-up appointments, during which
physicians complete an influenza follow-up form that
collects information on illness duration and severity.
Respiratory sample collection
Nasal and oropharyngeal swabs were chosen for respira-
tory sample collection to minimize risk to participants
and increase compliance with repeated sampling, as
these are the least invasive ways to collect samples for
respiratory virus testing. Swab samples are collected
Table 1 Questionnaires and surveys, Nicaraguan Pediatric influenza cohort study, Managua, Nicaragua, 2011–2013
Survey/Case report form Description
Medical consult form >80 item case report form completed by study nurses and physicians. Includes data on: height, weight,
tympanic temperature, blood pressure, respiratory and heart rates, lower and upper respiratory symptoms,
systemic symptoms, gastrointestinal symptoms, and nutritional status
Influenza follow-up form Collects daily information on 14 signs and symptoms. Filled out by physician at follow-up appointments
for all possible influenza cases.
Household annual SES and risk
factor survey
Questionnaire completed per household. Includes 31 questions on crowding, water access, socioeconomic
level, presence of animals, smoking and cooking inside the house.
Participant annual risk factor survey 44 questions focusing on medical history, socio-demographic information, individual risk factors and
vaccination
Height and weight survey Height and weight are measured twice. If there is >5 % difference between the two measurements, a
third measurement is taken.
Breastfeeding survey 9 questions about current and past breastfeeding
Satisfaction survey 12 questions about the quality of the service provided by study staff in different areas (admission,
nurses, physicians, clinical laboratory)
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using polyester-tipped plastic swabs. Both swabs are
inserted into a single tube containing 3 ml of viral trans-
port medium, which is labeled with a barcode; no per-
sonal identifying information is contained on the sample
label. For infants <6 months of age, a single oropharyn-
geal swab is collected. Samples are stored in the Clinical
Laboratory at the HCSFV at 4 °C and are transported to
the CNDR NVL for processing within 16 h of collection
on weekdays and within 48 h on weekends or holidays.
Data collection, management and security
Numerous tools are implemented to manage the large
amounts of data involved with study operation, providing
real-time monitoring and facilitating management of
screening processes, registration, and long-term follow-up
[12]. These tools are highly flexible and secure, and enable
compliance with GCP and regulatory guidelines, including
US federal regulations (21 CFR 11), via differentiated user
roles and privileges, password and user authentication se-
curity, and comprehensive auditing to record and monitor
access and data changes. The components of the custom
informatics system are presented in Additional file 1:
Table S1. OpenClinica is the main tool used for data man-
agement (OpenClinica LLC, Waltham, MA, https://open-
clinica.com/). OpenClinica was adapted for the NPICS
study and validated to ensure accuracy, reliability, consist-
ent performance, and an audit trail to track invalid/altered
records. The system produces accurate paper copies of
electronic records via data exports. Backup and restore
processes are documented and validated. As many data
and lab results as possible are entered automatically
through tablets, smart phones, barcodes, and electronic
transfer to study databases. When direct entry of data is
used, the software uses prompts for out-of-range data and
consistent terminology use. Data collection/entry is super-
vised, and double data entry is used, with multiple “check
functions” in place. Alteration of data is strictly controlled.
Data from field visits, the annual survey/sampling, and
clinical histories are collected directly into tablet com-
puters or smart phones to allow real-time access to data
and to minimize missing fields and data entry mistakes.
Applications for data entry are designed with appropriate
skip patterns and questions to verify responses. Use of
mobile devices with barcode scanners allows access to
study databases and the sample tracking system during
power outages, when essential study computers are main-
tained using backup batteries or a small power generator.
In the NVL, temperatures of all freezers, refrigerators, and
incubators are recorded via smart phones twice daily, and
graphical representations of temperature variation are
generated. In the HCSFV, mobile devices, GIS and bar-
codes are all utilized during field visits to participants’
homes [12]. The geographic localization of cohort partici-
pants are mapped using GIS, which is particularly useful
since Managua lacks addresses and street names. GIS-
generated maps are used in daily logistics of planning effi-
cient deployment of field teams [11].
Tracking samples and forms
Specimens and forms are tracked using a barcode system
to minimize data entry error and allow for real-time
tracking of all data and samples [10, 12]. Aviles et al.
[11] One-dimensional and two-dimensional barcodes are
used as appropriate for form or tube size. Barcodes for
sample storage at -80 °C or in liquid nitrogen are printed
on special labels (Cryocool, Zebra Technologies Corpor-
ation, Lincolnshire, IL). Each time a sample or form is
scanned, the date and time are automatically recorded.
Importantly, barcodes are scanned at each transfer be-
tween study personnel and sites and when processes are
completed. In the HCSFV, all medical consultation forms
are pre-printed with barcodes. Forms that are not used for
any reason are recorded in the database as a discarded
form to enable rapid identification any missing forms.
Mobile data collection and Dashboard
A custom informatics system for study fieldwork called
Dashboard was developed to improve the speed and
completeness of data and sample collection. Users and
roles for mobile data applications are configured into
the server backend. Before using applications in the
phone, all participant information in the dashboard is
synchronized with study databases using MySQL odbc
driver. With the application and forms installed in smart
phones and tablets, a valid user enters into the applica-
tion in the mobile device, and credentials are checked
on the server. If the user is validated, the application
synchronizes the data with the server, recording all in-
formation into the mobile database; this allows users to
work in the field without network connectivity if neces-
sary. In the application, users can search for a partici-
pant by barcode or by study code to pull up the
participant’s information and enter data. In the applica-
tion, Dashboard users can see participant information,
including household and demographic information, and
readily access information on other participants in the
household. The application indicates which processes re-
main to be completed for the participant, thereby in-
creasing data completeness, validates that all required
information is entered, and prompts the user to indicate
why missing data or samples are not being collected at
that time. Information collected on mobile devices
through Dashboard include the participant, household,
breastfeeding and study satisfaction surveys, height and
weight, sample data, field visits, consent data, vaccination
information, study gift receipt, supervisor sample recep-
tion, and sample temperature data. All information from
the mobile application, along with clinical laboratory
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information, is sent to the server to update the web moni-
toring dashboard in real-time.
In Dashboard, study personnel can review summary sta-
tistics and graphics, such as samples by day, type, neighbor-
hood, and study (Fig. 1). All sample and data information is
available in a searchable table. Dashboard has a quality con-
trol check built into the application to keep track of sam-
ples and shows immediately any discrepancy at any point in
the process, for example, if a sample is recorded as col-
lected but is not received by the laboratory. The application
also has a mapping function that can present samples col-
lected or samples to be collected in real-time (Fig. 2). This
graphical presentation assists supervisors to redirect field
staff to maximize productivity of field teams and eliminate
duplicated efforts. Finally, users can review information and
graphics about temperature, study gift receipt, and consent
collected by field teams. The system as a whole allows for
quick access to study information to make timely decisions
and maximize efficiency, facilitate logistics, and assure data
and sample quality.
Managing multiple studies
In addition to the NPICS, the HCSFV is also the site for
3 other large prospective field studies; a household study
Fig. 1 Custom web-based application, Dashboard
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of influenza transmission, an influenza birth cohort
study, and a Pediatric Dengue Cohort Study (PDCS).
Many of the participants are enrolled in more than one
study. For instance, there is substantial overlap of partic-
ipants ≥2 in the NPICS and the PDCS. Studying two dis-
eases in the same population enables more efficient use
of resources; however, extra checks must be imple-
mented to prevent protocol violations. Both electronic
and visual checks assist study personnel in identifying
the studies in which participants are enrolled and in col-
lecting appropriate samples and data. Electronic checks
alert personnel that the participant has not completed a
consent form, such as the DNA consent, or do not per-
mit a barcode to be printed for a research sample that
should not be collected (e.g., a respiratory sample for a
child only in the dengue cohort). Additionally, the par-
ticipants’ ID has a colored band that indicates the
study(s) in which the child is participating. Another im-
portant feature is that we try minimize the impact of
participating in multiple studies on the participant and
their family. The consent forms for each study specifically
grant permission for participants’ data and samples to be
shared between studies, both current and past/future. This
enables sharing data and annual samples between studies,
minimizing risks and burden for participants.
Capacity building
A number of initiatives have been conducted to
strengthen human capacity at the Ministry of Health sites
where the study is conducted. All new study personnel
participate in a 2-5-day training program that includes a
presentation on GCP, the NIH Human Subjects course,
and training in the study protocol and standard operating
procedures. Continuing personnel also receive training in
relevant areas. Training provided on-site through visits of
US-based investigators have included workshops on: bio-
statistics and STATA, sample collection, phylogenetics
and mathematical modeling, and the Responsible Conduct
of Research. Several training workshops and seminars
were facilitated through FHI360/NIAID: GCP, Data Man-
agement, Fundamentals of International Clinical Research,
and Clinical Research Design. The study also supported
the training of laboratory technicians and two in-country
MPH degrees. Additionally, training has been provided to
support study personnel in: NIH Program Funding &
Grants Administration and electronic Research Adminis-
tration. Altogether, this broad range of training opportun-
ities has significantly contributed to the current study and
has increased the research and administrative capacity at
the study sites.
Laboratory methods
RT-PCR
RNA is extracted from nasal and oropharyngeal
swabs using the QIAamp® Viral RNA Mini Kit (Qiagen
Corporation, Valencia, CA). Influenza viruses A and B are
amplified and typed/subtyped according to the protocol of
the Centers for Disease Control and Prevention (CDC).
Peripheral Blood Mononuclear Cells (PBMCs)
PBMCs are prepared from a subset of annual samples,
including repeat influenza virus infections. Briefly, blood
Fig. 2 Dashboard map of samples collected during the annual sample collection, 2014
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samples collected at the HCSFV or in the field are
promptly transported to the NVL/CNDR for immediate
processing, as described previously [13]. Time-stamps
are implemented at all stages from sample collection to
freezing to ensure sample integrity. Viability after thaw-
ing PBMCs is evaluated on a random selection of sam-
ples (90 % viability on average).
Discussion
Characteristics of study population and participation
Between January 1, 2011, and December 31, 2013, 1933
children participated in the NPICS. A flowchart of study
participation is presented in Fig. 3, and participant char-
acteristics in Table 2. Among the children, 1532 were
enrolled from all age groups between 0 and 12 years of
age at the start of the study and subsequently, 401 chil-
dren were enrolled over the following three years. Dur-
ing the first three years of the study, 268 (13.9 %)
children were withdrawn, lost-to-follow-up or died. The
mean yearly loss to follow-up was 4.6 % (range 2.5–
6.5 %). The main reasons that children were withdrawn
(n = 37) included that the child had reached the max-
imum age for the study, study physicians felt it was in
the child’s best interest, or the parent no longer wanted
the child to contribute respiratory or blood samples.
Four children died during the study; all deaths were in
children under the age of 1 year.
Children attended a total of 20,934 medical visits, in-
cluding 15,794 initial visits and 5140 follow-up visits. A
total of 1724 (89.2 %) children attended one or more
medical visits. The median number of medical visits per
child was 7 (range 0–108). Upper respiratory infections
were by far the most common reason for seeking med-
ical care, comprising a total of 9439 (59.8 %) initial visits
and 2143 (41.7 %) follow-up appointments. Reasons for
seeking medical care are summarized in Table 3. The
vast majority (91.6 %) of children with febrile illness pre-
sented in the first 4 days since onset of symptoms.
Study strengths
Much remains to be elucidated about the epidemiology
and transmission of influenza in tropical regions. Here we
describe the study design and methods of the Nicaraguan
Pediatric Influenza Cohort Study, which was established
to examine the incidence and risk factors for influenza in-
fection and disease severity in children and to study the
seasonality of influenza in Managua, Nicaragua. We show
that loss to follow-up was low, participants accessed med-
ical care regularly, and respiratory illness was the most
common reason for seeking medical care. We also de-
scribe our methods to increase adherence to study
2 Withdrawn            
72  Lost to follow-up      
1 Died
20 Withdrawn           
88  Lost to follow-up      
1 Died
15 Withdrawn           
27 Lost to follow-up      
2 Died
122 Newborns enrolled    
13 Children enrolled
 138 Newborns enrolled   
47 Children Enrolled
2014                    
1705  Children
2011                    
1532 Children Enrolled
2012                    
1538  Children 
2013                    
1564 Children
81 Newborns enrolled
Fig. 3 Flow chart of study participation
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protocols, comply with GCP, and conduct multiple
large-scale field studies in a single site using shared
infrastructure.
The NPICS evolved from and benefited from several
ongoing and past studies at this site, including the
Pediatric Dengue Cohort Study and our previous influ-
enza cohort study [8, 10]. Through all of these studies,
we were able to engage in significant local capacity
building, such as establishing molecular biological, viro-
logical, and serological influenza diagnostics in the NVL
and training local investigators in field study methodolo-
gies, including GCP. In addition, this study and our
other studies at the HCSFV serve as enhanced sentinel
sites for the Nicaraguan Ministry of Health, with influ-
enza results delivered in real-time to health officials. For
instance, during the 2009 pandemic, our ongoing influ-
enza study detected the first case of pandemic influenza
in the country, and the government was immediately
made aware.
The development of a customized, relatively low-
cost informatics system is one of the unique features
of this study. The informatics system was designed
in-house by the study informatics team not only to
increase efficiency and data completeness, but also to
enable researchers to minimize protocol deviations.
The issue of protocol deviations can become particu-
larly challenging when several protocols are run from
the same study site and participants can participate in
one or various studies. In particular, the Dashboard
developed for the study allows for real-time monitor-
ing of sample collection and helps prevent a child
from having their annual sample collected twice. All
of the informatics and database system complies with
US federal requirements (21 CFR 11).
Study Limitations
A major limitation of this study is that it relies on pas-
sive surveillance, that is the parents must bring the child
into the health center for care. The use of passive sur-
veillance will result in the underestimation of influenza
rates, particularly among less severe cases. To increase
compliance with attendance at the health center we have
made study care available 24 h a day, every day of the
year and have minimized wait time to see a physician. In
addition, we maintain regular contact with participants
and their families to encourage attendance for medical
care at the Health Center.
Conclusions
In summary, we have designed and implemented a large
community-based influenza cohort study in children in
Managua, Nicaragua, with high participation and com-
pliance with study procedures. We have designed a com-
prehensive, low-cost informatics system to aid in the
management of the study, increase data quality, and de-
crease protocol deviations. The cohort study is ongoing
and is continuing to provide essential information on
the burden and seasonality of influenza in Nicaraguan
children. We also demonstrate the successful integration
of two cohort studies (influenza and dengue) in the same
site and population, thus maximizing effective use of hu-
man, financial, and infrastructural resources.
Table 3 Reasons for medical visits, Nicaraguan Pediatric
Influenza Study, Managua, Nicaragua, 2011–2013
Initial Medical
Visits
Follow-up Visits Total
n = 15,794 n = 5140 n = 20,934
No. (%) No. (%) No. (%)
Upper respiratory 9439 (59.8) 2143 (41.7) 11,582 (55.3)
Lower respiratory 300 (1.9) 358 (6.7) 658 (3.1)
Gastrointestinal illness 1777 (11.2) 478 (9.3) 2255 (10.8)
Febrile illness 669 (4.2) 1067 (20.8) 1736 (8.3)
Dermatological 844 (5.3) 123 (2.4) 967 (4.6)
Trauma 435 (2.8) 36 (0.7) 471 (2.3)
Other 2300 (14.8) 935 (18.2) 3265 (15.6)
Table 2 Participant characteristics by year, Nicaraguan Pediatric
Influenza Cohort Study, Managua, Nicaragua, 2011–2013
2011 2012 2013
n = 1613 n = 1673 n = 1748
No. (%) No. (%) No. (%)
By sex
Female 814 (50.5) 844 (49.4) 884 (50.6)
Male 799 (49.5) 829 (49.6) 864 (49.4)
By age (years)
0 226 (14.0) 224 (13.4) 252 (14.4)
1 138 (8.6) 138 (8.2) 97 (5.6)
2 104 (6.4) 125(7.5) 129 (7.4)
3 119 (7.4) 97 (5.8) 116 (6.6)
4 108 (6.7) 114 (6.8) 131 (7.0)
5 108 (6.7) 104 (6.2) 108 (6.4)
6 125 (7.8) 104 (6.2) 101 (5.8)
7 123 (7.6) 121 (7.2) 98 (5.6)
8 130 (8.1) 118 (7.0) 116 (6.6)
9 144 (8.9) 123 (7.4) 113 (6.5)
10 150 (9.3) 134 (8.0) 113 (6.5)
11 137 (8.5) 142 (8.5) 122 (7.0)
12 1 (0.1) 129 (7.7) 136 (7.8)
13 - - 116 (6.6)
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Additional file 1: Table S1. Components of Custom Informatics
System, Nicaraguan Pediatric Influenza Cohort Study, Managua,
Nicaragua, 2011-2013. (DOC 46 kb)
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